
AL amyloidosis is a systemic disease caused by the deposition of fibrillar proteins in organs and tissues. These deposits are responsible for organic dysfunctions and may be rapidly lethal. Current therapy is unsatisfactory. We describe three clinical cases of multisystemic AL amyloidosis but with different initial presentation: nephrotic syndrome, cardiac failure and hepatic insufficiency. We review the literature about the clinical features, diagnostic methods and treatment of the disease.
Heart Failure, Male, Nephrotic Syndrome, Biopsy, Anti-Inflammatory Agents, Amyloidosis, Middle Aged, Prognosis, Diagnosis, Differential, Humans, Female, Immunoglobulin Light Chains, Steroids, Liver Failure, Aged
Heart Failure, Male, Nephrotic Syndrome, Biopsy, Anti-Inflammatory Agents, Amyloidosis, Middle Aged, Prognosis, Diagnosis, Differential, Humans, Female, Immunoglobulin Light Chains, Steroids, Liver Failure, Aged
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
